Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis.

ABSTRACT: Pharmacologic activation of stress-responsive signaling pathways provides a promising approach for ameliorating imbalances in proteostasis associated with diverse diseases. However, this approach has not been employed in vivo. Here we show, using a mouse model of myocardial ischemia/reperfusion, that selective pharmacologic activation of the ATF6 arm of the unfolded protein response (UPR) during reperfusion, a typical clinical intervention point after myocardial infarction, transcriptionally reprograms proteostasis, ameliorates damage and preserves heart function. These effects were lost upon cardiac myocyte-specific Atf6 deletion in the heart, demonstrating the critical role played by ATF6 in mediating pharmacologically activated proteostasis-based protection of the heart. Pharmacological

SUBMITTER: Blackwood EA 

PROVIDER: S-EPMC6331617 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature